← Leaderboards
Robert D Thompson
Adenosine Therapeutics, Llc
$4,905,559
Attributed
$4,905,559
Total exposure
8
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $755.5K · FY2005–07$1M$750K$500K$250K$0
'05
'06
'07
Funding mix
By agency
NIH$4,905,559 · 8
By mechanism
R44$2,901,596 · 3
R42$943,553 · 1
R43$773,908 · 2
R41$286,502 · 2
Top collaborators
No co-investigators on record.
Most similar at Adenosine Therapeutics, Llc
Same institution · by research overlap
- William M Scheld$633,055
- Robert A Figler$1,624,445
Others in their field
Top investigators on “Purinergic Receptor”
- Wolfgang G Junger · University Of California San Diego$11,704,048
- Bruce Neil Cronstein · New York University School Of Medicine$10,758,078
- Joel M. Linden · University Of Virginia Charlottesville$9,578,056
- David B Peden · University Of North Carolina Chapel Hill$9,209,178
- Gyorgy Hasko · Univ Of Med/Dent Of Nj-Nj Medical School$9,177,820
- Simon C Robson · Massachusetts General Hospital$7,881,677
Research focus
Purinergic ReceptorDrug Design /Synthesis /ProductionAdenosineAntiinflammatory AgentsLaboratory MousePharmacokineticsDrug Screening /EvaluationStimulant /AgonistBiotechnologyReperfusionNeuroanatomyLaboratory RabbitInflammationSpinal Cord InjuryNeuropharmacologic AgentSwineDosage FormsDisease /Disorder Prevention /ControlNeuropharmacologyBiotherapeutic AgentNeurophysiologyNeuroprotectantsSlow Release DrugThoracic Surgery
Grant awards (13)
Antagonists of A2B Adenosine Receptors for Asthma$685,117
R44 · FY2007 · AI · contact PI
Antagonists of A2B Adenosine Receptors for Asthma$755,496
R44 · FY2006 · AI · contact PI
A2A Adenosine Receptor Agonist for the Treatment of IBD$335,663
R43 · FY2005 · DK
A2a Adenosine Agonists for Diabetic Nephropathy$147,326
R41 · FY2005 · DK
A2a Adenosine Blockers for Parkinson's Disease$139,176
R41 · FY2005 · NS
A2A Adenosine Receptor Agonist for the Treatment of IBD$337,360
R43 · FY2004 · DK
A2a Adenosine Agonists as Neuroprotectants$471,081
R44 · FY2003 · NS
A2a Adenosine Agonists Limit Damage from Infection$427,450
R42 · FY2003 · AI
Novel Adenosine A2A Agonists in Renal Tissue Protection$394,934
R44 · FY2003 · DK
Long Acting Agonists of Adenosine A2a Receptors$100,885
R43 · FY2003 · HL
A2a Adenosine Agonists Limit Damage from Infection$516,103
R42 · FY2002 · AI
A2a Adenosine Agonists as Neuroprotectants$457,679
R44 · FY2002 · NS
A2a Adenosine Agonists as Neuroprotectants$137,289
R44 · FY2002 · NS